Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Bio-Rad projects 2025 currency-neutral revenue growth of 1.5%-3.5%, excluding contributions from acquisitions. Diagnostics revenue is expected to grow between 2%-3%, while Life Science revenue is ...

Exploring sustainable blister packaging from the lens of material selection, quality regulations, machinability, and ...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...

SandboxAQ today announced it has expanded its relationship with Deloitte to offer SandboxAQ's AI LQM simulation products and solutions along with Deloitte's services capabilities to organizations ...

RedHill Biopharma Ltd (RDHL) reported its Q1 2022 earnings, revealing a decrease in net revenues to $18.2 million from $22.1 million in the previous quarter. Despite this, the company achieved a gross ...

Highlights,Revised valuation estimates from reputable financial sources (NASDAQ:REGN),Strong quarterly earnings with revenue ...

Highlights,Fulcrum Therapeutics has received varied ratings, reflecting diverse perspectives on its market ...

Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report)’s share price crossed above its 50 day moving average during trading on Friday .The stock has a 50 day moving average of $11.18 and ...

UCB was a new entrant among the top 20 biopharmaceutical companies, doubling its market capitalisation from $16.9bn in 2023 to $38.7bn in 2024. Source: GlobalData, Pharma Intelligence Center; Stock ...

DNA Script announced a significant advancement in oligonucleotide synthesis technology, enabling the production of custom DNA sequences of up to 500 nucleotides in length with unprecedented sequence ...